Indium Oxyquinoline

CHEMBL2110573 Phase 4 Approuvé Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

— g/mol

LogP

—

Phase

4

This compound is used in nuclear medicine to label white blood cells or other cells outside the body with radioactive indium-111, which are then reinjected to track inflammation, infection, or tumors inside the body. The oxyquinoline (oxine) acts as a carrier to move indium across cell membranes.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

This compound is used in nuclear medicine to label white blood cells or other cells outside the body with radioactive indium-111, which are then reinjected to track inflammation, infection, or tumors inside the body. The oxyquinoline (oxine) acts as a carrier to move indium across cell membranes.

Yes, Indium Oxyquinoline is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2110573. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Indium Oxyquinoline sur PillFYI

Données Clés

Synonymes: 1

Liens externes

ChEMBL CHEMBL2110573

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.